The Patent Finder

Bio-Technology General Corporation

Also on record
Records under this name other than patents Bio-Technology General Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Bio-Technology General Corporation

PatentTitleStatus Expires Confidence
US 6,610,520Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
Formerly held
Term ended
Term ended Aug 26, 2020 · From the USPTO record
Term endedTerm ended Aug 26, 2020From the USPTO record
US 6,576,659Use of oxandrolone in the treatment of burns an other wounds
Formerly held
Term ended
Term ended Dec 5, 2017 · From the USPTO record
Term endedTerm ended Dec 5, 2017From the USPTO record
US 6,828,313Use of Oxandrolone in the Treatment of Burns and Other Wounds
Formerly held
Term ended
Term ended Dec 5, 2017 · Medium confidence
Term endedTerm ended Dec 5, 2017Medium confidence
US 6,054,291Expression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methods
Formerly held
Term ended
Term ended Jun 9, 2017 · From the USPTO record
Term endedTerm ended Jun 9, 2017From the USPTO record
US 6,030,611Therapeutic SOD compositions and uses thereof
Formerly held
Term ended
Term ended Feb 28, 2017 · From the USPTO record
Term endedTerm ended Feb 28, 2017From the USPTO record
US 6,010,875Expressions plasmids containing the deo promoter, and bacterial hosts containing the plasmids
Formerly held
Term ended
Term ended Jul 25, 2016 · From the USPTO record
Term endedTerm ended Jul 25, 2016From the USPTO record
US 6,090,799Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
Formerly held
Term ended
Term ended Jun 22, 2015 · From the USPTO record
Term endedTerm ended Jun 22, 2015From the USPTO record
US 7,132,510Specific Human Antibodies for Selective Cancer Therapy
Formerly held
Lapsed on the fee record
Ended Nov 7, 2014 · High confidence
Lapsed on the fee recordEnded Nov 7, 2014High confidence
US 6,670,351Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
Formerly held
Term ended
Ended no later than Oct 20, 2012 · From the USPTO record
Term endedEnded no later than Oct 20, 2012From the USPTO record
US 6,121,426Fibrin binding domain polypeptides and uses and methods of producing same
Formerly held
Lapsed on the fee record
Ended Sep 19, 2012 · From the USPTO record
Lapsed on the fee recordEnded Sep 19, 2012From the USPTO record
10 of 79 patents shown.
Pro members see all 79.
Pro members: see all 79 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited